Skip to content

PUMA BIOTECHNOLOGY, INC.: filings

Every PUMA BIOTECHNOLOGY, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 61 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-06fiscal Q2 2026441210001437749-26-026311
10-Q2026-05-07fiscal Q1 202645890001437749-26-015633
10-K2026-02-26fiscal FY 2025511270001437749-26-005891
10-Q2025-11-06fiscal Q3 2025461250001437749-25-033633
10-Q2025-08-07fiscal Q2 2025461250001437749-25-025470
10-Q2025-05-08fiscal Q1 202546910001437749-25-015533
10-K2025-02-27fiscal FY 2024501260001437749-25-005496
10-Q2024-11-07fiscal Q3 2024461250001437749-24-033955
10-Q2024-08-01fiscal Q2 2024461250001437749-24-024309
10-Q2024-05-02fiscal Q1 202444870001437749-24-014395
10-K2024-02-29fiscal FY 2023471180001437749-24-006121
10-Q2023-11-02fiscal Q3 2023451230001437749-23-030028
10-Q2023-08-03fiscal Q2 2023451230001437749-23-021972
10-Q2023-05-04fiscal Q1 202243850001437749-23-012589
10-K2023-03-02fiscal FY 2022471180001437749-23-005233
10-Q2022-11-03fiscal Q3 2022441170001437749-22-025787
10-Q2022-08-04fiscal Q2 2022451210001437749-22-018920
10-Q2022-05-05fiscal Q1 202245870001437749-22-011142
10-K2022-03-03fiscal FY 2021451120001437749-22-005164
10-Q2021-11-04fiscal Q3 2021461230001437749-21-025298
10-Q2021-08-05fiscal Q2 2021481250001564590-21-041634
10-Q2021-05-06fiscal Q1 202146880001564590-21-024942
10-K2021-03-01fiscal FY 2020501650001564590-21-009840
10-Q2020-11-05fiscal Q3 2020461170001564590-20-051427
10-Q2020-08-06fiscal Q2 2020481270001564590-20-037821
10-Q2020-05-07fiscal Q1 202043850001564590-20-022888
10-K2020-02-28fiscal FY 2019451450001564590-20-007591
10-Q2019-11-07fiscal Q3 2019441100001564590-19-041793
10-Q2019-08-09fiscal Q2 2019431080001564590-19-031182
10-Q2019-05-10fiscal Q1 201943830001564590-19-018584
10-K2019-03-01fiscal FY 2018431310001564590-19-005830
10-Q2018-11-05fiscal Q3 2018411020001564590-18-026644
10-Q2018-08-09fiscal Q2 201841980001564590-18-021046
10-Q2018-05-10fiscal Q1 201835670001564590-18-013008
10-K2018-03-09fiscal FY 2017381090001564590-18-005152
10-Q2017-11-09fiscal Q3 201732790001564590-17-023226
10-Q2017-08-09fiscal Q2 201727740001564590-17-016942
10-Q2017-05-10fiscal Q1 201727560001564590-17-010232
10-K2017-03-01fiscal FY 2016291000001564590-17-003090
10-Q2016-11-09fiscal Q3 201628750001564590-16-028617
10-Q2016-08-09fiscal Q2 201628750001564590-16-023661
10-Q2016-05-10fiscal Q1 201628570001564590-16-018945
10-K2016-02-29fiscal FY 201528960001564590-16-013716
10-Q2015-11-09fiscal Q3 201528760001564590-15-010147
10-Q2015-08-10fiscal Q2 201528760001564590-15-006819
10-Q2015-05-11fiscal Q1 201527560001564590-15-003915
10-K2015-03-02fiscal FY 201428950001564590-15-001193
10-Q2014-11-10fiscal Q3 201427930001564590-14-005392
10-Q2014-08-11fiscal Q2 201427920001564590-14-003464
10-Q2014-05-12fiscal Q1 201428740001193125-14-194791
10-K2014-03-03fiscal FY 2013301050001193125-14-080183
10-Q2013-11-12fiscal Q3 201330930001193125-13-438277
10-Q2013-08-06fiscal Q2 201330920001193125-13-321498
10-Q2013-05-09fiscal Q1 201330740001193125-13-211141
10-K2013-04-01fiscal FY 201228770001193125-13-136650
10-Q2012-11-14fiscal Q3 201225730001193125-12-469037
10-Q2012-08-14fiscal Q2 201226720001193125-12-355553
10-Q2012-05-15fiscal Q1 201225570001193125-12-234886
10-K2012-03-29fiscal FY 201125480001193125-12-139883
10-Q2011-11-14fiscal Q3 201118460001193125-11-311276
10-Q2011-08-15fiscal Q2 201111430001144204-11-047512

Inspect the source

Entity
PUMA BIOTECHNOLOGY, INC. / CIK 0001401667
Captured
2026-09-20T08:00:41.213Z
SEC response SHA-256
4b2b449f06e175eebf840b512ad515ef71296ad006f32415c1f427849828bc3d

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001401667.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))